Published January 1989 | Version v1
Report

Treatment of carcinoma of head and neck with a combination of conventional irradiation and methotrexate as radiosensitizer

  • 1. National Cancer Inst., Bangkok (Thailand)

Description

Between 6 February 1984 to 11 September 1986, 200 cases of cancer of head and neck were randomised into control group (105), i.e. conventional irradiation treatment and trial group (95), i.e. MTX 50 mg. i.v. on day 1 and followed by conventional irradiation. Early complications were tolerable as well as late complications. Good response rate in trial group was significant. One case in trial group developed a second primary. Long term benefit is to be documented. (author). 16 refs, 7 tabs

Part of:
Improvement of cancer therapy by the combination of conventional radiation and chemical or physical means

Additional details

Publishing Information

Imprint Title
Improvement of cancer therapy by the combination of conventional radiation and chemical or physical means
Imprint Pagination
170 p.
Journal Page Range
p. 91-104.
Report number
IAEA-TECDOC--493

INIS

Country of Publication
International Atomic Energy Agency (IAEA)
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
20049105
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
CHEMOTHERAPY; DOSE-RESPONSE RELATIONSHIPS; FRACTIONATED IRRADIATION; HEAD; LARYNX; METHOTREXATE; NECK; NEOPLASMS; PATIENTS; RADIATION DOSES; RADIOSENSITIZERS; RADIOTHERAPY; SIDE EFFECTS; SURVIVAL CURVES
Descriptors DEC
ANTIMETABOLITES; BODY; BODY AREAS; DISEASES; DRUGS; IRRADIATION; MEDICINE; RESPIRATORY SYSTEM; RESPONSE MODIFYING FACTORS; THERAPY

Optional Information

Contract/Grant/Project number
Grant IAEA-323-E3-RC-277.2